240 related articles for article (PubMed ID: 29996538)
1. Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer.
Inamura K; Takazawa Y; Inoue Y; Yokouchi Y; Kobayashi M; Saiura A; Shibutani T; Ishikawa Y
J Clin Med; 2018 Jul; 7(7):. PubMed ID: 29996538
[TBL] [Abstract][Full Text] [Related]
2. Tumor B7-H3 (CD276) expression and smoking history in relation to lung adenocarcinoma prognosis.
Inamura K; Yokouchi Y; Kobayashi M; Sakakibara R; Ninomiya H; Subat S; Nagano H; Nomura K; Okumura S; Shibutani T; Ishikawa Y
Lung Cancer; 2017 Jan; 103():44-51. PubMed ID: 28024695
[TBL] [Abstract][Full Text] [Related]
3. Tumor B7-H3 expression in diagnostic biopsy specimens and survival in patients with metastatic prostate cancer.
Amori G; Sugawara E; Shigematsu Y; Akiya M; Kunieda J; Yuasa T; Yamamoto S; Yonese J; Takeuchi K; Inamura K
Prostate Cancer Prostatic Dis; 2021 Sep; 24(3):767-774. PubMed ID: 33558663
[TBL] [Abstract][Full Text] [Related]
4. Cancer Cell B7-H3 Expression Is More Prevalent in the Pancreato-Biliary Subtype of Ampullary Cancer Than in Pancreatic Cancer.
Geerdes EE; Sideras K; Aziz MH; van Eijck CH; Bruno MJ; Sprengers D; Boor PPC; Kwekkeboom J
Front Oncol; 2021; 11():615691. PubMed ID: 33996541
[TBL] [Abstract][Full Text] [Related]
5. Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma.
Inamura K; Amori G; Yuasa T; Yamamoto S; Yonese J; Ishikawa Y
Cancer Manag Res; 2019; 11():7021-7030. PubMed ID: 31440091
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node-Negative, p53-Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma.
Chen X; Zhang Y; Mo S; Ma H; Lu Z; Yu S; Chen J
Arch Pathol Lab Med; 2023 Apr; 147(4):465-473. PubMed ID: 35862858
[TBL] [Abstract][Full Text] [Related]
7. A three-phase trans-ethnic study reveals
Gao Y; Xu Y; Gao M; Huang A; Chi P
J Gastrointest Oncol; 2021 Dec; 12(6):2891-2905. PubMed ID: 35070416
[TBL] [Abstract][Full Text] [Related]
8. Clinical Significance of the Expression of Co-Stimulatory Molecule B7-H3 in Papillary Thyroid Carcinoma.
Zhao B; Huang Z; Zhu X; Cai H; Huang Y; Zhang X; Zhang Z; Lu H; An C; Niu L; Li Z
Front Cell Dev Biol; 2022; 10():819236. PubMed ID: 35493085
[No Abstract] [Full Text] [Related]
9. Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer.
Loos M; Hedderich DM; Ottenhausen M; Giese NA; Laschinger M; Esposito I; Kleeff J; Friess H
BMC Cancer; 2009 Dec; 9():463. PubMed ID: 20035626
[TBL] [Abstract][Full Text] [Related]
10. Immune checkpoint of B7-H3 in cancer: from immunology to clinical immunotherapy.
Zhao B; Li H; Xia Y; Wang Y; Wang Y; Shi Y; Xing H; Qu T; Wang Y; Ma W
J Hematol Oncol; 2022 Oct; 15(1):153. PubMed ID: 36284349
[TBL] [Abstract][Full Text] [Related]
11. Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma.
Cattaneo G; Ventin M; Arya S; Kontos F; Michelakos T; Sekigami Y; Cai L; Villani V; Sabbatino F; Chen F; Sadagopan A; Deshpande V; Moore PA; Ting DT; Bardeesy N; Wang X; Ferrone S; Ferrone CR
Cancer Lett; 2024 Apr; 587():216713. PubMed ID: 38364961
[TBL] [Abstract][Full Text] [Related]
12. B7-H3/CD276: An Emerging Cancer Immunotherapy.
Zhou WT; Jin WL
Front Immunol; 2021; 12():701006. PubMed ID: 34349762
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis.
Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
[TBL] [Abstract][Full Text] [Related]
14. B7-H3 and B7-H4 are independent predictors of a poor prognosis in patients with pancreatic cancer.
Xu H; Chen X; Tao M; Chen K; Chen C; Xu G; Li W; Yuan S; Mao Y
Oncol Lett; 2016 Mar; 11(3):1841-1846. PubMed ID: 26998087
[TBL] [Abstract][Full Text] [Related]
15. B7-H3 is regulated by BRD4 and promotes TLR4 expression in pancreatic ductal adenocarcinoma.
Zhao J; Meng Z; Xie C; Yang C; Liu Z; Wu S; Wang B; Fan P; Jin X; Wu H
Int J Biochem Cell Biol; 2019 Mar; 108():84-91. PubMed ID: 30664982
[TBL] [Abstract][Full Text] [Related]
16. Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas.
Zang X; Sullivan PS; Soslow RA; Waitz R; Reuter VE; Wilton A; Thaler HT; Arul M; Slovin SF; Wei J; Spriggs DR; Dupont J; Allison JP
Mod Pathol; 2010 Aug; 23(8):1104-12. PubMed ID: 20495537
[TBL] [Abstract][Full Text] [Related]
17. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer.
Si S; Wang L; Cao H; Xu Y; Zhan Q
BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310
[TBL] [Abstract][Full Text] [Related]
18. Expression and Clinical Significance of Immune Checkpoint Regulator B7-H3 (CD276) in Human Meningioma.
Deng J; Ma M; Wang D; Zhu H; Hua L; Sun S; Chen H; Cheng H; Qian ZR; Xie Q; Zhang T; Gong Y
World Neurosurg; 2020 Mar; 135():e12-e18. PubMed ID: 31629137
[TBL] [Abstract][Full Text] [Related]
19. Clinical importance of B7-H3 expression in human pancreatic cancer.
Yamato I; Sho M; Nomi T; Akahori T; Shimada K; Hotta K; Kanehiro H; Konishi N; Yagita H; Nakajima Y
Br J Cancer; 2009 Nov; 101(10):1709-16. PubMed ID: 19844235
[TBL] [Abstract][Full Text] [Related]
20. B7-H3 on circulating epithelial tumor cells correlates with the proliferation marker, Ki-67, and may be associated with the aggressiveness of tumors in breast cancer patients.
Pizon M; Schott DS; Pachmann U; Pachmann K
Int J Oncol; 2018 Nov; 53(5):2289-2299. PubMed ID: 30226585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
